Expanded use of minimally invasive mitral valve surgery will be the No. 2 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
It’s increasingly clear that there’s no good reason to delay surgical repair in patients with primary mitral valve disease and severe regurgitation. Two experts share perspectives about what that means in practice.
Experts advise on developments to look for in the transcatheter space when it comes to managing diseases of the mitral, tricuspid and pulmonary valves.
Nothing teaches as well as a good case. That’s the thinking behind the case-based design of this 1.5-day multidisciplinary exploration of mitral valve management.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The mitral valve poses anatomic challenges to transcatheter treatment that the aortic valve doesn’t. Here’s a glimpse into six ongoing studies designed to overcome them.
If the world-class faculty, spirited pro/con debates and unprecedently comprehensive agenda aren’t enough, then come for December sightseeing in New York.
Here’s the skinny on three new or emerging technologies that promise to make mitral valve procedures less invasive and/or more efficient.